DIABECELL®

uses pig islets to replace human islets that have been destroyed by type 1 diabetes.

Our Team
Board directors
     Executives

Incorporated in New Zealand, DOL is a privately owned company formed as a joint venture between Living Cell Technologies and Otsuka Pharmaceutical Factory. As equal shareholders, both companies have equal representation on the board of directors.

Our current directors are: 

 

Professor Robert Elliott, MBBS, MD, FRACP, CNZM, Director Living Cell Technologies

 

Mr Hiromi Yoshikawa, Senior Managing Director Finance, Legal & IP, IT, Licensing, US Business Development, India Business at Otsuka Pharmaceutical Factory Inc.


Dr Kinji Hashimoto,  PhD, Executive Managing Director, Research & Development and Quality Assurance at Otsuka Pharmaceutical Factory Inc.


Mr Roy Austin, Chairperson of Living Cell Technologies


Shaun Wynyard

MSc (Hons)

General Manager & Head of Molecular Diagnostics

Incorporated in New Zealand, DOL is a privately owned company formed as a joint venture between Living Cell Technologies and Otsuka Pharmaceutical Factory. As equal shareholders, both companies have equal representation on the board of directors.

Our current directors are: 

 

Professor Robert Elliott, MBBS, MD, FRACP, CNZM, Director Living Cell Technologies

 

Mr Hiromi Yoshikawa, Senior Managing Director Finance, Legal & IP, IT, Licensing, US Business Development, India Business at Otsuka Pharmaceutical Factory Inc.


Dr Kinji Hashimoto,  PhD, Executive Managing Director, Research & Development and Quality Assurance at Otsuka Pharmaceutical Factory Inc.


Mr Roy Austin, Chairperson of Living Cell Technologies


Board directors

Incorporated in New Zealand, DOL is a privately owned company formed as a joint venture between Living Cell Technologies and Otsuka Pharmaceutical Factory. As equal shareholders, both companies have equal representation on the board of directors.

Our current directors are: 

 

Professor Robert Elliott, MBBS, MD, FRACP, CNZM, Director Living Cell Technologies

 

Mr Hiromi Yoshikawa, Senior Managing Director Finance, Legal & IP, IT, Licensing, US Business Development, India Business at Otsuka Pharmaceutical Factory Inc.


Dr Kinji Hashimoto,  PhD, Executive Managing Director, Research & Development and Quality Assurance at Otsuka Pharmaceutical Factory Inc.


Mr Roy Austin, Chairperson of Living Cell Technologies


Executives

Incorporated in New Zealand, DOL is a privately owned company formed as a joint venture between Living Cell Technologies and Otsuka Pharmaceutical Factory. As equal shareholders, both companies have equal representation on the board of directors.

Our current directors are: 

 

Professor Robert Elliott, MBBS, MD, FRACP, CNZM, Director Living Cell Technologies

 

Mr Hiromi Yoshikawa, Senior Managing Director Finance, Legal & IP, IT, Licensing, US Business Development, India Business at Otsuka Pharmaceutical Factory Inc.


Dr Kinji Hashimoto,  PhD, Executive Managing Director, Research & Development and Quality Assurance at Otsuka Pharmaceutical Factory Inc.


Mr Roy Austin, Chairperson of Living Cell Technologies